[1]白盈盈,朱光旭,潘兴华.长链非编码RNA对结直肠癌潜在诊断价值的研究进展[J].现代检验医学杂志,2018,33(01):161-164.[doi:10.3969/j.issn.1671-7414.2018.01.001]
点击复制

长链非编码RNA对结直肠癌潜在诊断价值的研究进展()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年01期
页码:
161-164
栏目:
综述
出版日期:
2018-02-05

文章信息/Info

文章编号:
1671-7414(2018)01-161-04
作者:
白盈盈12朱光旭1潘兴华1
1.成都军区昆明总医院 细胞生物治疗中心, 细胞生物医药技术国家地方联合工程实验室,云南省干细胞工程实验室,昆明 650032; 2.昆明医科大学 成都军区昆明总医院临床学院,昆明 650500
关键词:
长链非编码RNA 结直肠癌 生物学标记物
分类号:
R735.3; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.01.001
文献标志码:
A
摘要:
摘 要:结直肠癌是常见的恶性肿瘤,其发病率和死亡率均有上升趋势。有效的诊断方式是提高结直肠癌患者生存的关键,但是现有的检测方法,如结肠镜、粪便潜血试验等,在结直肠癌诊断中均有局限性。长链非编码RNA是近年来的研究热点,长链非编码RNA的异常表达与结直肠癌的发生、发展密切相关。该文就长链非编码RNA与结直肠癌的诊断进行一简要综述。

参考文献/References:

[1] Siegel RL,Miller KD,Jemal A.CancerStatistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.
[2] Chen WQ,Zheng RS,Baade PD,et al.Cancer statistics inChina,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[3] Kanthan R,Senger JL,Kanthan SC.Molecular events in primary and metastatic colorectal carcinoma:A review[J].Pathol Res Int,2012(2012):597497.
[4] Kadiyska T,Nossikoff A.Stool DNA methylation assays in colorectal cancer screening[J].World J Gastroenterol,2015,21(35):10057-10061.
[5] Roberts TC,Morris KV,Weinberg MS.Perspectives on the mechanism of transcriptional regulation by long non-coding RNA[J].Epigenetics,2014,9(1):13-20.
[6] Ponting CP,Oliver PL,Reik W.Evolution and functions of long non-coding RNAs[J].Cell,2009,136(4):629-641.
[7] Guttman M,Rinn JL.Modular regulatory principles of large non-coding RNAs[J].Nature,2012,482(7385):339-346.
[8] Mercer TR,Dinger ME,Mattick JS.Long non-coding RNAs:insights into functions[J].Nat Rev Genet,2009,10(3):155-159.
[9] Li QE,Ye GL,Guo JM.Long non-coding RNA,a new star sparkling in cancer molecular diagnosis[J].Chin J Biochem Mol Biol,2014,30(3):233-240.
[10] Xiang JF,Yin QF,Chen T,et al.Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus[J].Cell Res,2014,24(5):513-531.
[11] Cai B,Song XQ,Cai JP,et al.HOTAIR:a cancer-related long non-coding RNA[J].Neoplasma,2014,61(4):379-391.
[12] Hu ZY,Wang XY,Guo WB,et al.Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells[J].Oncotarget,2016,7(10):11733-11743.
[13] Han P,Li JW,Zhang BM,et al.The lncRNA CR-NDE promotescolorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling[J].Mol Cancer,2017,16(1):9.
[14] Yang XJ,Huang CQ,Peng CW,et al.Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression[J].Gene,2016,592(1):172-178.
[15] Kasagi Y,Oki E,Ando K,et al.The expression of CCAT2,a novel long noncoding RNA transcript,and rs6983267 single-nucleotide polymorphism genotypesin colorectal cancers[J].Oncology,2017,92(1):48-54.
[16] Xiang JF,Yin QF,Chen T,et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus[J].Cell Res,2014,24(5):513-531.
[17] Yin DD,Liu ZJ,Zhang E,et al.Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer[J].Tumour Biol,2015,36(6):4851-4859.
[18] Yin DD,He XZ,Zhang EB,et al.Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer[J].Med Oncol,2014,31(11):253.
[19] Qi P,Xu MD,Ni SJ,et al.Down-regulation of ncRAN,a long non-codingRNA,contributes to colorectal cancer cell migration and invasion and predictspoor overall survival for colorectal cancer patients[J].Mol Carcinog,2015,54(9):742-750.
[20] Yang WW,Ning N,Jin XM.The lncRNA H19 promotes cell proliferation by competitively binding to miR-200a and derepressing β-catenin expression in colorectal cancer[J].Biomed Res Int,2017,2017(3):2767484.
[21] Ji P,Diederichs S,Wang W,et al.MALAT-1,a novel noncoding RNA,andthymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer[J].Oncogene,2003,22(39):8031-8041.
[22] 常建兰,李祖国,王晓燕,等.p53,malat1,ki-67和β-catenin基因mRNA 检测在大肠癌分子诊断中的意义[J].世界华人消化杂志,2008,16(34):3849-3854. Chang JL,Li ZG,Wang XY,et al.Detection of p53,malatl1,ki-67 and β-catenin mRNA expression and its significance in molecular diagnosis of colorectal carcinoma[J].World Chinese Journal of Digestology,2008,16(34):3849-3854.
[23] Zheng HT,Shi DB,Wang YW,et al.High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer[J].Int J Clin Exp Pathol,2014,7(6):3174-3181.
[24] Nissan A,Stojadinovic A,Mitrani-Rosenbaum S,et al.Colon cancer associated transcript-1:a novel RNA expressed in malignant and pre-malignant human tissues[J].Int J Cancer,2012,130(7):1598-1606.
[25] 崔 戈,张 婷,崔 杰.结肠癌相关转录因子1表达在结直肠癌早期筛查及预后评估中的作用[J].南京医科大学学报(自然科学版),2015,35(7):1008-1012. Cui G,Zhang T,Cui J.Value of colon cancer associated transcription factor 1 expression in early screening and prognosis assessment for patients with colorectal carcinoma[J].Acta Universitatis Medicinalis Nanjing(Natura Science),2015,35(7):1008-1012.
[26] Kam Y,Rubinstein A,Naik S,et al.Detection of a long non-coding RNA(CCAT1)in living cells and human adenocarcinoma of colon tissues using FIT-PNAmolecular beacons[J].Cancer Lett,2014,352(1):90-96.
[27] Ellis BC,Graham LD,Molloy PL.CRNDE,a long non-coding RNA responsiveto insulin/IGF signaling,regulates genes involved in central metabolism[J].Biochim Biophys Acta,2014,1843(2):372-386.
[28] Graham LD,Pedersen SK,Brown GS,et al.Colorectal neoplasia differentially expressed(CRNDE),a novel gene with elevated expression in colorectal adenomas and adenocarcinomas[J].Genes Cancer,2011,2(8):829-840.
[29] Liu T,Zhang X,Gao S,et al.Exosomal long noncoding RNA CRNDE-h as anovel serum-based biomarker for diagnosis and prognosis of colorectal cancer[J].Oncotarget,2016,7(51):85551-85563.
[30] Rinn JL,Keaesz M,Wang JK,et al.Functional demarcation of active andsilent chromatin domains in human HOX loci by noncoding RNA[J].Cell,2007,129(7):1311-1323.
[31] Kogo R,Shimamura T,Mimori K,et al.Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers[J].Cancer Res,2011,71(20):6320-6326.
[32] Svoboda M,Slyskova J,Schneiderova M,et al.HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors,but also in the blood of colorectal cancer patients[J].Carcinogenesis,2014,35(7):1510-1515.
[33] 林 洋,许利剑.长链非编码RNA在结直肠癌中的研究进展[J].医学研究生报,2016,29(5):556-560. Lin Y,Xu LJ.Research progress of long non-coding RNAs in colorectal cancer[J].J Med Postgra,2016,29(5):556-560.
[34] Zhao WM,Song M,Zhang J,et al.Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma[J].Int J Clin Exp Pathol,2015,8(11):14131-14140.
[35] Wan LD,Kong JL,Tang JL,et al.HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor[J].J Cell Mol Med,2016,20(11):2036-2044. 收稿日期:2017-06-10 修回日期:2017-10-09

相似文献/References:

[1]王钦君,张红春,申娴娟,等.MicroRNAs作为结直肠癌潜在标记物的研究进展[J].现代检验医学杂志,2015,30(04):107.[doi:10.3969/j.issn.1671-7414.2015.04.031]
 WANG Qin-jun,ZHANG Hong-chun,SHEN Xian-juan,et al.MicroRNAs as a Potential Marker in the Progress of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2015,30(01):107.[doi:10.3969/j.issn.1671-7414.2015.04.031]
[2]张 振,李 芬.ceRNA与肿瘤[J].现代检验医学杂志,2016,31(04):128.[doi:10.3969/j.issn.1671-7414.2016.04.036]
[3]洪 宏,袁建芬,喻海忠.乳腺癌患者血清长链非编码RNA ATB 表达水平检测及临床诊断价值[J].现代检验医学杂志,2020,35(02):22.[doi:10.3969 / j.issn.1671-7414.2020.02.007]
 HONG Hong,YUAN Jian-fen,YU Hai-zhong.Detection and Clinical Diagnosis Value of Serum Long Non-codingRNA ATB in Patients with Breast Cancer[J].Journal of Modern Laboratory Medicine,2020,35(01):22.[doi:10.3969 / j.issn.1671-7414.2020.02.007]
[4]李 悦,徐焕铭,樊 华.基于TCGA 数据对60 岁以上不同分层急性髓系白血病患者相关lncRNA 的基因信息学分析[J].现代检验医学杂志,2020,35(03):20.[doi:10.3969/j.issn.1671-7414.2020.03.005]
 LI Yue,XU Huan-ming,FAN Hua.Genetic Informatics Analysis of lncRNA Related to Patients with Different Stratified Acute Myeloid Leukemia Over 60 Years Based on TCGA Database[J].Journal of Modern Laboratory Medicine,2020,35(01):20.[doi:10.3969/j.issn.1671-7414.2020.03.005]
[5]梁晓虎,郭俊霞,雷尚昆.食管癌组织中lnc RNA DNAJC3-AS1的表达及其与临床病理特征的相关性研究[J].现代检验医学杂志,2021,36(02):75.[doi:doi:10.3969/j.issn.1671-7414.2021.02.018]
 LIANG Xiao-hu,GUO Jun-xia,LEI Shangkun.Expression of Lnc RNA DNAJC3-AS1 in Esophageal Carcinoma Tissues and Its Correlation with Clinicopathological Features[J].Journal of Modern Laboratory Medicine,2021,36(01):75.[doi:doi:10.3969/j.issn.1671-7414.2021.02.018]
[6]刘 霄a,黄晓燕b,王建华a.长链非编码RNASNHG9在不同肿瘤中的最新研究进展[J].现代检验医学杂志,2021,36(04):176.[doi:10.3969/j.issn.1671-7414.2021.04.038]
 LIU Xiaoa,HUANG Xiao-yanb,WANG Jian-huaa.Reasearch Progress of Long Non-coding RNA SNHG9 in Different Tumors[J].Journal of Modern Laboratory Medicine,2021,36(01):176.[doi:10.3969/j.issn.1671-7414.2021.04.038]
[7]朱 娇a,孙国才b,刘素荣a,等.食管癌患者血清神经元特异性烯醇化酶与长链非编码RNA ITGA9-AS1水平联合检测的实验诊断价值研究[J].现代检验医学杂志,2021,36(05):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
 ZHU Jiaoa,SUN Guo-caib,LIU Su-ronga,et al.Experimental Diagnostic Value of Combined Detection of SerumNeuron-Specific Enolase and Long Non-Coding RNA ITGA9-AS1 inPatients with Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(01):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
[8]刘立民,刘雪香,邹 燕,等.长链非编码RNA调控CD4+T淋巴细胞增殖分化和在免疫性疾病中的最新研究进展[J].现代检验医学杂志,2021,36(06):200.[doi:10.3969/j.issn.1671-7414.2021.06.044]
 LIU Li-min,LIU Xue-xiang,ZOU Yan,et al.Roles of lncRNA in Regulating the Proliferation, Differentiation of CD4+T Lymphocytes and Immune Diseases[J].Journal of Modern Laboratory Medicine,2021,36(01):200.[doi:10.3969/j.issn.1671-7414.2021.06.044]
[9]张文娟,郭 逸,段 勇,等.健康献血者机采血小板储存中LncRNA LIPCAR 的表达及初步研究[J].现代检验医学杂志,2023,38(03):119.[doi:10.3969/j.issn.1671-7414.2023.03.021]
 ZHANG Wen-juan,GUO Yi,DUAN Yong,et al.Expression and Preliminary Study of LncRNA LIPCAR in Platelet Storage of Mechanically Collected Platelets from Healthy Blood Donors[J].Journal of Modern Laboratory Medicine,2023,38(01):119.[doi:10.3969/j.issn.1671-7414.2023.03.021]
[10]李 轶a,尚 立b.非酒精性脂肪肝病患者血清LncRNA PVT1 表达水平与胰岛素抵抗及肝纤维化的相关性研究[J].现代检验医学杂志,2023,38(05):80.[doi:10.3969/j.issn.1671-7414.2023.05.015]
 LI Yia,SHANG Lib.Correlation of Serum LncRNA PVT1 Expression Level with Insulin Resistance and Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease[J].Journal of Modern Laboratory Medicine,2023,38(01):80.[doi:10.3969/j.issn.1671-7414.2023.05.015]

备注/Memo

备注/Memo:
L(¨overu)SM.Pattern of prenatal screening and diagnosis for down syndrome suitable to corrent stute in China[J].Journal of Diagnostics Concepts & Practice,2010,9(5):413-417. [2] WS322.1-2010.胎儿常见染色体异常与开发性神经管缺陷的产前筛查与诊断技术标准第1部分:中孕期母血清学产前筛查[S].北京:中国标准出版社,2010. Ministry of Health People's Republic of China.W S322.1-2010.Technical standards of prenatal screening and diagnosis for fetal common chromosomal abnormalities and open neural tube defects Part1.Maternal serum prenatal screening in second trimester[S].Beijing:Standards Press of China,2010. [3] 边旭明,蒋宇林.重视唐氏综合征产前筛查的质量控制和评估[J].实用妇产科杂志,2014,30(2):81-83. Bian XM,Jiang YL.Quality control and evaluation of the prenatal screening of Down's syndrome[J].Journal of Practical Obstetric and Gynecology,2014,30(2):81-83. [4] 姜 萍,张风琴,苍金荣.唐氏综合征和神经管畸形筛查实验的临床应用[J].现代检验医学杂志,2007,22(5):106-108. Jiang P,Zhang FQ,Cang JR.The clinical application of Down's syndrome and neural tube defects screening experiment[J].J Mod Lab Med,2007,22(5):106-108. [5] 朱宝生,朱 姝.唐氏综合征血清学产前筛查室内质控的目标与方法[J].实用妇产科杂志,2014,30(2):89-93. Zhu BS,Zhu S.The goal and method of screening indoor quality control of the blood qingxue prenatal screening of down syndrome[J].Journal of Practical Obstetrics and Gynecology,2014,30(2):89-93. [6] 刘珊玲,王 和.唐氏综合征产前筛查实验室质量控制[J].中华检验医学杂志,2011,34(7):665-668. Liu SL,Wang H.Laboratory quality control for Do-wn's syndrome[J].Clin J Lab Med,2011,34(7):665-668. [7] 王治国.临床检验方法确认与性能验证[M].北京:人民卫生出版社,2014. Wang ZG.Clinical test method validation and performance verification[M].Beijing:People's Health Press,2014. 收稿日期:2017-04-26 修回日期:2017-10-11
更新日期/Last Update: 2018-02-07